White House data sharing plan boasts big ambitions, but has scant details
Improving health data exchange is a worthy goal, but the initiative so far includes few details on how it will work — and has plenty of barriers to overcome, experts say.
CMS to root out undocumented immigrants enrolled in Medicaid
CMS will provide states monthly reports of beneficiaries whose citizenship or immigration status cannot be confirmed. States are expected to take “appropriate actions” including limiting coverage, the agency said.
Judge overturns rule limiting broker payments in Medicare Advantage
Reed O’Connor’s ruling is a setback for smaller MA plans — and efforts to curb predatory marketing to seniors.
Medicare Advantage headwinds dinging member satisfaction: survey
Overall customer satisfaction with MA plans fell 29 points year over year, driven by a declining level of member trust in their health plans, according to J.D. Power.
Elevance loses Medicare Advantage star ratings suit
The Texas judge’s decision — which picked apart Elevance’s argument on mathematical grounds — could cost Elevance $375 million, though the insurer could still appeal.
Veradigm appoints new CEO
Don Trigg, an alum of primary care and navigation firm Apree Health and EHR vendor Cerner, will take up the role on Sept. 2.
Large employers forecast ‘daunting’ 9% hike in healthcare costs next year
Employers surveyed by the Business Group on Health are bracing for the largest annual increase in healthcare costs in more than a decade — a sobering prospect, one expert said.
Private equity owners led to Genesis Healthcare’s bankruptcy: report
The skilled nursing operator filed for bankruptcy in July, a “predictable” outcome after years of financial mismanagement from Genesis’ private equity investors, according to the Private Equity Stakeholder Project.
Pay gap between hospital CEOs and workers on the rise: study
The average wage of chief executives rose by 27.5% from 2009 to 2023, while the average pay for all hospital employees rose 9.8%, according to research in Health Affairs.
Kennedy’s mRNA cuts could set US science back, experts warn
Scientists say HHS’ decision to defund mRNA vaccine research will leave the country less prepared for pandemics, and make it harder to invest in companies advancing the technology.